Peerless
Established in 2001 and headquartered in Chennai, India, the company supplies in-vitro diagnostic instruments, reagents, disposables and home-healthcare products across India through a large distributor network. It operates two manufacturing units in Chennai, maintains a sales and service field force, and partners with international suppliers to source diagnostic and laboratory equipment.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Clinical chemistry analyzers (semi-automated and fully automated)
Analytical instruments and reagents for clinical chemistry testing suitable for diagnostic laboratories.
Hematology analyzers (3‑part and 5‑part differential)
Hematology instruments with 3‑part and 5‑part differential capabilities for complete blood counts.
Immunoassay systems (CLIA, TR-FIA)
Automated immunoassay analyzers and test kits for quantitative and qualitative immunoassay testing.
Point-of-care testing devices and consumables
POCT devices such as blood glucose monitoring systems, HbA1c and hemoglobin point‑of‑care analyzers, and associated strips and disposables.
Rapid lateral-flow diagnostic tests
A portfolio of rapid lateral‑flow tests for infectious and endemic diseases (e.g., dengue, malaria, typhoid, leptospira, syphilis, HBsAg).
Laboratory consumables and blood collection tubes
Supply of vacuum and non‑vacuum blood collection tubes, needles and routine clinical disposables.
Clinical chemistry analyzers (semi-automated and fully automated)
Analytical instruments and reagents for clinical chemistry testing suitable for diagnostic laboratories.
Hematology analyzers (3‑part and 5‑part differential)
Hematology instruments with 3‑part and 5‑part differential capabilities for complete blood counts.
Immunoassay systems (CLIA, TR-FIA)
Automated immunoassay analyzers and test kits for quantitative and qualitative immunoassay testing.
Point-of-care testing devices and consumables
POCT devices such as blood glucose monitoring systems, HbA1c and hemoglobin point‑of‑care analyzers, and associated strips and disposables.
Rapid lateral-flow diagnostic tests
A portfolio of rapid lateral‑flow tests for infectious and endemic diseases (e.g., dengue, malaria, typhoid, leptospira, syphilis, HBsAg).
Laboratory consumables and blood collection tubes
Supply of vacuum and non‑vacuum blood collection tubes, needles and routine clinical disposables.
Services
Distribution services for diagnostic instruments, reagents and healthcare products through a pan‑India distributor network with logistics and payment support.
Installation, commissioning and technical maintenance services for laboratory analyzers and lab equipment delivered by an in‑house sales & service team.
Onshore manufacturing and supply of reagents, disposables and consumables for clinical testing and point‑of‑care products.
Distribution services for diagnostic instruments, reagents and healthcare products through a pan‑India distributor network with logistics and payment support.
Installation, commissioning and technical maintenance services for laboratory analyzers and lab equipment delivered by an in‑house sales & service team.
Onshore manufacturing and supply of reagents, disposables and consumables for clinical testing and point‑of‑care products.
Expertise Areas
- In-vitro diagnostics (IVD)
- Point-of-care testing (POCT)
- Clinical chemistry
- Hematology instrumentation
Key Technologies
- Chemiluminescence immunoassay (CLIA)
- Time-resolved fluorescence immunoassay (TR-FIA)
- Immunoturbidimetry
- Semi-automated and fully automated clinical chemistry analyzers
News & Updates
Established two operational manufacturing facilities in Chennai to support local production.
Reached a landmark of 2,000 installations of semi‑automated clinical chemistry analyzers.
Launched a new home healthcare division in April 2022 to expand product offerings in homecare.
Reported sales turnover of INR 144 crore for fiscal year 2021-22 and stated medium‑term revenue targets.
Established two operational manufacturing facilities in Chennai to support local production.
Reached a landmark of 2,000 installations of semi‑automated clinical chemistry analyzers.
Launched a new home healthcare division in April 2022 to expand product offerings in homecare.
Reported sales turnover of INR 144 crore for fiscal year 2021-22 and stated medium‑term revenue targets.